Oligonucleotide therapeutics: A step forward

被引：41

作者：

Gewirtz, AM ^{[1
]}

机构：

[1] Univ Penn, Sch Med, Philadelphia, PA 19104 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2000年 / 18卷 / 09期

关键词：

D O I：

10.1200/JCO.2000.18.9.1809

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1809 / 1811

页数：3

共 38 条

[1] DEGRADATION OF MESSENGER-RNA IN EUKARYOTES [J].

BEELMAN, CA ;

PARKER, R .

CELL, 1995, 81 (02) :179-183

[2] BINDING, UPTAKE, AND INTRACELLULAR TRAFFICKING OF PHOSPHOROTHIOATE-MODIFIED OLIGODEOXYNUCLEOTIDES [J].

BELTINGER, C ;

SARAGOVI, HU ;

SMITH, RM ;

LESAUTEUR, L ;

SHAH, N ;

DEDIONISIO, L ;

CHRISTENSEN, L ;

RAIBLE, A ;

JARETT, L ;

GEWIRTZ, AM .

JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (04) :1814-1823

[3] Phase I trial of an antisense oligonucleotide OL(1)p53 in hematologic malignancies [J].

Bishop, MR ;

Iversen, PL ;

Bayever, E ;

Sharp, JG ;

Greiner, TC ;

Copple, BL ;

Ruddon, R ;

Zon, G ;

Spinolo, J ;

Arneson, M ;

Armitage, JO ;

Kessinger, A .

JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (04) :1320-1326

[4] Clinical use of streptolysin-O to facilitate antisense oligodeoxyribonucleotide delivery for purging autografts in chronic myeloid leukaemia [J].

Clark, RE ;

Grzybowski, J ;

Broughton, CM ;

Pender, NT ;

Spiller, DG ;

Brammer, CG ;

Giles, RV ;

Tidd, DM .

BONE MARROW TRANSPLANTATION, 1999, 23 (12) :1303-1308

[5] BCR-ABL antisense oligodeoxynucleotide in vitro purging and autologous bone marrow transplantation for patients with chronic myelogenous leukemia in advanced phase [J].

de Fabritiis, P ;

Petti, MC ;

Montefusco, E ;

De Propris, MS ;

Sala, R ;

Bellucci, R ;

Mancini, M ;

Lisci, A ;

Bonetto, F ;

Geiser, T ;

Calabretta, B ;

Mandelli, F .

BLOOD, 1998, 91 (09) :3156-3162

[6] Lessons learned from the development of an Abl tyrosine kinase inhibitor for chronic myelogenous leukemia [J].

Druker, BJ ;

Lydon, NB .

JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (01) :3-7

[7] The hammerhead ribozyme [J].

Eckstein, F .

BIOCHEMICAL SOCIETY TRANSACTIONS, 1996, 24 (03) :601-604

[8] Cancer genetics: Tumor suppressor meets oncogene [J].

Fearon, ER ;

Dang, CV .

CURRENT BIOLOGY, 1999, 9 (02) :R62-R65

[9] Nucleic acid therapeutics: State of the art and future prospects [J].

Gewirtz, AM ;

Sokol, DL ;

Ratajczak, MZ .

BLOOD, 1998, 92 (03) :712-736

[10] Facilitating oligonucleotide delivery: Helping antisense deliver on its promise - Commentary [J].

Gewirtz, AM ;

Stein, CA ;

Glazer, PM .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (08) :3161-3163

← 1 2 3 4 →